On 11 January 2022, the European Commission and MHRA approved Kaftrio for eligible children aged 6-11 in England, Scotland, Wales and Northern Ireland.

See CF trust update for more information. We will be in touch with those eligible to arrange all tests needed to prescribe and discuss with you what this means for you

Toggle search Open search menu icon SEARCH THE SITE Open contact page icon Contact Parking icon Find & Parking
Royal Devon and Exeter NHS logo

Welcome to the Exeter CF Research page!


It is a hugely exciting time for CF Research, with many clinical trials and research projects going on. Various topics are being investigated including studies looking at quality of life and investigating new treatments, as well as comparing existing treatments.

The CF Trust have launched the Clinical Trials Accelerator Platform (often shortened to CTAP) to help increase participation and improve access to clinical trials for people with CF in the UK. Exeter has been awarded CTAP status for both adult and paediatric services meaning Exeter is part of a network leading CF Research in the UK.

As part of the Accelerator Platform, Exeter has appointed a full time CF Trials Coordinator Sophie Whiteley who facilitates trial set up and running at Exeter with the Research Nurses and Practitioners alongside your usual care team. If you have any questions about research or are interested in taking part in a study, please contact Sophie at s.whiteley1@nhs.net or 01392 406981

The CF Trust has many resources with information about taking part in research. What are clinical trials? Follow this link to the CF Trust clinical trials hub, where you can also access information about taking part in clinical trials and the trials tracker (to see where research is happening around the UK)